TelASK has participated in dozens of published randomised trials and research collaborations with leading institutions across North America. Every QPM outcome claim is grounded in peer-reviewed evidence. Use our ROI calculators to model the specific impact for your organisation.
TelASK is currently supporting the following active research program with our patient engagement and data collection infrastructure.
Peer-reviewed evidence underpinning every QPM outcome claim. The QPM platform was used to support all of the studies listed below. Filter by topic.
Choose your context below.
TelASK welcomes the opportunity to collaborate on research programs designed to evaluate how new technologies and communication strategies improve patient outcomes. If you have a project in mind, let's talk.
Automated IVR, SMS, and email platforms with established randomised trial protocols
Bi-directional Epic integration with structured outcome capture and audit trails
Established partnerships with state quitline vendors across the US and Canada
21 published studies; active collaborations with MGH, MUSC, McGill, and more